Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Illinois Wellness Insider.
Press releases published on July 14, 2025
Strength Training For Women: CrazyBulk Legal Steroid Alternatives Are Changing the Muscle Building Supplements Game
GlobeNewswire
·
July 14, 2025
New York City, NY, July 14, 2025 (GLOBE NEWSWIRE) -- Introduction: Why Strength Training for Women Is Evolving in 2025 In 2025, strength training is no longer confined to male-dominated gym floors. Across the globe, more women are stepping into power racks …
Survey: Public Health Workers Are Younger, Committed, and Burned Out
GlobeNewswire
·
July 14, 2025
Bethesda, Md., July 14, 2025 (GLOBE NEWSWIRE) -- Findings from the 2024 Public Health Workforce Interests and Needs Survey (PH WINS) provide a unique snapshot of the government public health workforce, including the evolving demographics, job …
The Foundation for Sarcoidosis Research Awards $450,000 to Support Early-Career Investigators Through the 2025 Fellowship Grant
GlobeNewswire
·
July 14, 2025
CHICAGO, July 14, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the three recipients of the 2025 FSR Early Career Fellowship Grant: William Lippitt, PhD, (University of Colorado Anschutz Medical Campus), Juan …
Ascentage Pharma Announces Pricing of Top-Up Placement
GlobeNewswire
·
July 14, 2025
ROCKVILLE, Md. and SUZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) (“Ascentage” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in …
TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets
GlobeNewswire
·
July 14, 2025
SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and founded and led by Anne Wojcicki, today announced that it has completed the acquisition of the Personal Genome …
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
GlobeNewswire
·
July 14, 2025
Tevogen.AI’s model drastically reduces target analysis and has the potential to generate billions in cost savings across the healthcare system by streamlining early-stage drug discovery, reducing wet lab dependency, and accelerating timelines. Beyond cost …
BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis
GlobeNewswire
·
July 14, 2025
First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting antibiotic-resistant lung infections in Cystic Fibrosis patients; topline results are expected in Q1 2026 Prior Phase 1b/2a efficacy …
Borvo EVAC™ System Demonstrates 100% Success Rate in Chronic Subdural Hematoma Clinical Cases Validated Across 5 Medical Centers
GlobeNewswire
·
July 14, 2025
MOUNTAIN VIEW, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Borvo Medical, a neurosurgical medtech startup and a portfolio company of NeuroTechnology Investors (NTI), today announced a 100% success rate across five medical centers using the FDA-cleared Borvo …
Pineapple, Inc. to Launch Real-World Asset Token Designed to Monetize Intellectual Property
GlobeNewswire
·
July 14, 2025
Tokenized IP platform built to enable access, utility, and engagement with Pineapple branded proprietary assets LOS ANGELES, CA, July 14, 2025 (GLOBE NEWSWIRE) -- Pineapple, Inc. (OTC: PNPL) (“Pineapple” or the “Company”) today announced its strategic …
NEXGEL and STADA AG Announce Expansion of Partnership for North America
GlobeNewswire
·
July 14, 2025
LANGHORNE, Pa., July 14, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced expanding its …
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
GlobeNewswire
·
July 14, 2025
Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to increase SCOTTSDALE, Ariz., July 14, 2025 (GLOBE NEWSWIRE) -- Journey …
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
GlobeNewswire
·
July 14, 2025
July 14, 2025 Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a …
Derma Fillers Market worth $7.32 billion by 2030 with 12.1% CAGR | MarketsandMarkets™.
GlobeNewswire
·
July 14, 2025
Delray Beach, FL, July 14, 2025 (GLOBE NEWSWIRE) -- The global derma fillers market, valued at US$3.74 billion in 2024 stood at US$4.13 billion in 2025 and is projected to advance at a resilient CAGR of 12.1% from 2025 to 2030, culminating in a forecasted …
Ciao Bella! Euro Summer Starts Right Here in Canada at Chopped Leaf
GlobeNewswire
·
July 14, 2025
Oakville, Ontario, Canada, July 14, 2025 (GLOBE NEWSWIRE) -- OAKVILLE, ON – Fresh, light and full of flavour, Chopped Leaf is introducing two new low-calorie, summer-fresh salads: the Antipasto Salad and Peach Caprese Salad, available across Canada …
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
GlobeNewswire
·
July 14, 2025
WATERTOWN, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
GlobeNewswire
·
July 14, 2025
HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company received notification from The Nasdaq Stock Market LLC (Nasdaq) of an additional extension to …
Vivos Inc. Submitted the Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Clinic
GlobeNewswire
·
July 14, 2025
Kennewick, WA, July 14, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a pioneer in Precision Radionuclide TherapyTM (PRnT) solutions, today announced the submission of its Investigational Device Exemption (IDE) application to the U.S. Food and Drug …
Pilot Light Unveils Updated Food Education Standards to Transform How Students Learn Through Food
GlobeNewswire
·
July 14, 2025
Chicago, July 14, 2025 (GLOBE NEWSWIRE) -- Pilot Light today announced the release of its updated Food Education Standards, the first-ever comprehensive framework for integrating Food Education into PreK-12 classrooms. The revised standards build on five …
Full Alliance Group Launches Qubitera Holdings, to Develop Quant Blockchain and YAHBEE Wallet for Healthcare and Web3
GlobeNewswire
·
July 14, 2025
TAMPA, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group Inc. (OTC: FAGI) today announced the formation of Qubitera Holdings, Inc., a majority-owned subsidiary (80% ownership), created to lead the development of decentralized infrastructure and …
Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial
GlobeNewswire
·
July 14, 2025
SAN MATEO, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced results from an independent, real- …